ArticleVaccines2022

Production and Purification of LTB-RBD: A Potential Antigen for Mucosal Vaccine Development against SARS-CoV-2.

Karla I Solis-Andrade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.